Cargando…

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma

PURPOSE: Pancreatic adenocarcinoma (PAAD) is characterized by low antitumour immune cell infiltration in an immunosuppressive microenvironment. This study aimed to systematically explore the impact on prognostic alternative splicing events (ASs) of tumour immune microenvironment (TIME) in PAAD. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bo, Deng, Tuo, Deng, Liming, Yu, Haitao, He, Bangjie, Chen, Kaiyu, Zheng, Chongming, Wang, Daojie, Wang, Yi, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590242/ https://www.ncbi.nlm.nih.gov/pubmed/34772375 http://dx.doi.org/10.1186/s12885-021-08962-7

Ejemplares similares

Laparoscopic Versus Open Surgery for Early-Stage Intrahepatic Cholangiocarcinoma After Mastering the Learning Curve: A Multicenter Data-Based Matched Study
por: Jinhuan, Yang, et al.
Publicado: (2022)

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
por: Ye, Zai-Sheng, et al.
Publicado: (2021)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment
por: Wang, Gongjun, et al.
Publicado: (2021)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma
por: Ma, Shouzheng, et al.
Publicado: (2022)

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer
por: Deng, Youyuan, et al.
Publicado: (2021)

Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma
por: Yang, Jinhuan, et al.
Publicado: (2022)

Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma
por: Huang, Tianpeng, et al.
Publicado: (2021)

Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma
por: Qu, Yaqi, et al.
Publicado: (2020)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors
por: Wang, Yidi, et al.
Publicado: (2020)

A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy
por: Deng, Liming, et al.
Publicado: (2021)

The role of tumour microenvironment: a new vision for cholangiocarcinoma
por: Chen, Ziyan, et al.
Publicado: (2018)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
por: Yu, Shanshan, et al.
Publicado: (2021)

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
por: Weng, Yuanchi, et al.
Publicado: (2023)

The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

The prognostic value of sarcopenia combined with preoperative fibrinogen–albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study
por: Yu, Haitao, et al.
Publicado: (2021)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Tumor microenvironment–associated modifications of alternative splicing
por: Brosseau, Jean-Philippe, et al.
Publicado: (2014)

Exploration of Alternative Splicing (AS) Events in MDV-Infected Chicken Spleens
por: Wang, Lulu, et al.
Publicado: (2021)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment
por: Zhang, Nan, et al.
Publicado: (2020)

Comprehensive characterization of 11 prognostic alternative splicing events in ovarian cancer interacted with the immune microenvironment
por: Yue, Congbo, et al.
Publicado: (2022)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
por: Deng, Liming, et al.
Publicado: (2023)

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas
por: Lin, Peng, et al.
Publicado: (2018)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment
por: Xue, Meilin, et al.
Publicado: (2023)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Comprehensive identification of internal structure and alternative splicing events in circular RNAs
por: Gao, Yuan, et al.
Publicado: (2016)

Systematic Profiling of Alternative Splicing Events in Ovarian Cancer
por: Liu, Jia, et al.
Publicado: (2021)

SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
por: Dai, Jing, et al.
Publicado: (2023)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
por: Zhao, Liang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32vvni72a3ll799k95sko4qqqc